Hospital
Brigham and Women's
Brigham and Women's was paid $771K by Medicaid between May 2019 and May 2020, across 54 billing codes. Its largest line is G0378, Hospital observation service, per hour — 30% of everything it billed.
33Billing provider infoBRIGHAM AND WOMEN'S
BOSTON, MA 02135
BOSTON, MA 02135
33aNPI1881790020assigned 09/15/2006
33bProvider typeCritical Access Hospital
28Total paid$771K
24GClaims7,135
24DCodes billed54
24AFirst – last monthMay 2019 – May 2020
Compared with peers
Next to other Critical Access Hospital providers in Massachusetts
Rank by total paid#4 of 5
Median peer was paid$7.11M
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 4,624 | $534K | |
| 2020 | 2,511 | $237K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0378 | Hospital observation service, per hour | 30% | 269 | 137 | $229K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 295 | 287 | $112K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 144 | 137 | $91K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 434 | 412 | $90K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 6.2% | 379 | 357 | $48K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.1% | 184 | 169 | $24K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.4% | 121 | 111 | $18K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.3% | 144 | 123 | $17K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.8% | 598 | 518 | $14K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 607 | 553 | $13K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.6% | 41 | 41 | $13K |
| 71046 | Radiologic examination, chest; 2 views | 1.5% | 186 | 182 | $12K |
42 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.4% | 290 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 229 | $10K |
| 80076 | 1.1% | 380 | $9K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 78 | $8K |
| 83735 | <1% | 283 | $5K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 88 | $5K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 32 | $5K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 88 | $5K |
| 81025 | <1% | 233 | $4K | |
| 83690 | <1% | 163 | $3K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 13 | $3K |
| 86850 | <1% | 90 | $3K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 13 | $2K |
| 84484 | <1% | 55 | $2K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 13 | $2K |
| 81001 | <1% | 231 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 106 | $2K |
| 85610 | <1% | 146 | $2K | |
| 86900 | <1% | 104 | $2K | |
| 86901 | <1% | 104 | $2K | |
| 84702 | <1% | 37 | $1K | |
| 85027 | <1% | 57 | $901.55 | |
| 83605 | <1% | 26 | $847.47 | |
| 71045 | Radiologic examination, chest; single view | <1% | 18 | $811.44 |
| 81003 | <1% | 142 | $768.50 | |
| 87081 | <1% | 48 | $577.87 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 168 | $545.17 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 13 | $514.19 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 13 | $472.64 |
| 80053 | Comprehensive metabolic panel | <1% | 17 | $409.71 |
| 85730 | <1% | 14 | $203.28 | |
| 84100 | <1% | 13 | $184.92 | |
| 87088 | <1% | 13 | $166.68 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 18 | $111.41 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 79 | $95.49 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 40 | $61.09 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 71 | $32.40 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 41 | $28.02 |
| J2704 | Injection, propofol, 10 mg | <1% | 14 | $26.45 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 124 | $25.50 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 12 | $8.80 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBRACH, ROBERT (PHYSICIAN ASSISTANT)